View Older Stories View More Recent Stories
-
Windstream to Sell Data Center Business for $575 Million
-
RBC Capital Starts Endologix (ELGX) at Outperform
-
Canadian Oil Sands' Board Unanimously Recommends Shareholders Reject Undervalued, Opportunistic and Exploitive Suncor Offer
-
Investors may face rough ride if Canadian election leads to political instability
-
TransFirst (TF) Files $100M Common Stock IPO
-
TransFirst Files Registration Statement for Initial Public Offering
-
Mimecast Limited Files Registration Statement for Proposed Initial Public Offering
-
Mimecast (MIME) Files for $100M Common Stock IPO
-
Email security provider Mimecast files for U.S. IPO
-
Alibaba (BABA) Looks to Broaden Exposure to Secular Internet Trends in China with Youku (YOKU) Deal - RBC
-
RBC And Youth INC Partner To Bring RBC Race For The Kids To Downtown Manhattan On October 17
-
Jarden Corp. (JAH) Prices 10M Common Offering at $49/Share
-
Dollar gains on Fed rate-hike, ECB stimulus bets
-
Jarden Announces Pricing Of Common Stock Offering
-
RBC Capital Cuts Price Target on Seagate Technology (STX) Following Quarterly Pre-Announcement
-
Fitch Publishes New Issue Report for Venture XVIII CLO, Limited/LLC
-
RBC Capital Remains Bullish on Netflix (NFLX) Following 3Q Results
-
Zafgen (ZFGN) PT Lowered to $46 at RBC Capital; Discusses Road Ahead for Beloranib
-
DDR Prices $400 Million Offering of 4.250% Senior Unsecured Notes
-
National Retail Properties, Inc. Prices Offering Of $400,000,000 Of 4.00% Senior Unsecured Notes Due 2025
-
Media General Reaches Agreement with Meredith Under Which Media General Will Exchange Information with Nexstar Broadcasting Group
-
Barrick Announces Pricing for Debt Tender Offer
-
Square Files Registration Statement for Proposed Initial Public Offering
-
Square (SQ) Files for $275M Common Stock IPO
-
Netflix Releases Third-Quarter 2015 Financial Results
-
RBC Sees 33% of Zafgen (ZFGN) Death Happening in Placebo Arm; Reiterates 'Outperform' Rating
-
Zafgen (ZFGN) Worst Case Scenario Avoided, RBC Capital - Bloomberg
-
RBC Explains the Details Behind the TRIP/PCLN Agreement (TRIP) (PCLN) (EXPE)
-
RBC Positive on TripAdvisor (TRIP), Priceline (PCLN) Deal; Will be Slightly Negative for Expedia (EXPE)
-
Notable Analyst Rating Changes 10/14: (ADI) (DPLO) (INTC) Upgraded; (GPRO) (TWTR) (SB) Downgraded
-
RBC Capital Raises Price Target on Intel (INTC) Following 3Q EPS Beat
-
RBC Capital Remains Bullish on NetApp (NTAP) Following Annual Conference
-
Barrick Announces Early Tender Date Results of Debt Tender Offer and Amendment to Maximum Tender Amount
-
RBC Capital Starts RPM International (RPM) at Sector Perform
-
BofA's cost cuts cushion blow from weak rates, muted trading
-
RBC Capital Starts Eastman Chemical (EMN) at Outperform
-
RBC Capital Starts Celanese (CE) at Sector Perform
-
RBC Capital Starts Axalta Coating Systems (AXTA) at Outperform
-
Chipotle Mexican (CMG) PT Raised to $825 at RBC Capital; Expects Accelerating Sales Momentum
-
Curetis Announces Intention to Launch Its Initial Public Offering and Listing on Euronext Amsterdam and Euronext Brussels
-
Zafgen (ZFGN) Won't Comment on 56% Stock Plunge
-
Zafgen (ZFGN) Continues Free Fall Into Close Amid Radio Silence
-
Analysts Not Impressed by Twitter's (TWTR) Cost Cutting
-
Streetinsider.com's Hot Lunchtime Reads 10/13: (TSLA) (TXMD) (FIG) (ACI)
-
RBC Capital Discusses Theoretical Scenarios Following Zafgen's (ZFGN) Plunge
-
Notable Analyst Rating Changes 10/13: (TOL) (MPEL) (POT) Upgraded; (ACI) (SKYW) (PHM) Downgraded
-
Twitter announces layoffs as CEO Dorsey looks to revive growth
-
The JCRA Group Expands Its Canadian Operations by Appointing Hugh Sutcliffe as Director and Head of JCRA Canada Inc.
-
RBC Capital Starts Nabriva Therapeutics AG (NBRV) at Outperform
-
RBC Capital Starts Synthetic Biologics (SYN) at Outperform, PT $8

